Brevital Sodium (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Brevital Sodium drug offered from Par Pharmaceutical, Inc.. This Barbiturate [EPC],Barbiturates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: methohexital sodium
SUBSTANCE NAME: METHOHEXITAL SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Barbiturate [EPC],Barbiturates [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS; RECTAL
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2007-11-01
END MARKETING DATE: 0000-00-00


Brevital Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBrevital Sodium from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE: CIV
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2007-11-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42023-105_e387f9d3-5b2e-4359-88ab-1ce750c42c66
PRODUCT NDC: 42023-105
APPLICATION NUMBER: NDA011559

Other METHOHEXITAL SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Par Pharmaceutical, Inc.Brevital Sodium